ABCL
Price
$3.49
Change
+$0.03 (+0.87%)
Updated
Dec 3 closing price
Capitalization
1.04B
82 days until earnings call
Intraday BUY SELL Signals
TELO
Price
$1.32
Change
+$0.03 (+2.33%)
Updated
Dec 3 closing price
Capitalization
45.38M
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs TELO

Header iconABCL vs TELO Comparison
Open Charts ABCL vs TELOBanner chart's image
AbCellera Biologics
Price$3.49
Change+$0.03 (+0.87%)
Volume$3.36M
Capitalization1.04B
Telomir Pharmaceuticals
Price$1.32
Change+$0.03 (+2.33%)
Volume$179.83K
Capitalization45.38M
ABCL vs TELO Comparison Chart in %
View a ticker or compare two or three
VS
ABCL vs. TELO commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and TELO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ABCL: $3.47 vs. TELO: $1.30)
Brand notoriety: ABCL and TELO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 36% vs. TELO: 3%
Market capitalization -- ABCL: $1.04B vs. TELO: $45.38M
ABCL [@Biotechnology] is valued at $1.04B. TELO’s [@Biotechnology] market capitalization is $45.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileTELO’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • TELO’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than TELO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 6 TA indicator(s) are bullish while TELO’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 6 bullish, 4 bearish.
  • TELO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than TELO.

Price Growth

ABCL (@Biotechnology) experienced а -4.14% price change this week, while TELO (@Biotechnology) price change was -0.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

ABCL is expected to report earnings on Feb 24, 2026.

TELO is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.05B) has a higher market cap than TELO($45.4M). ABCL YTD gains are higher at: 18.430 vs. TELO (-68.447). TELO has higher annual earnings (EBITDA): -16.08M vs. ABCL (-197.92M). ABCL has more cash in the bank: 553M vs. TELO (754K). ABCL has higher revenues than TELO: ABCL (32.9M) vs TELO (0).
ABCLTELOABCL / TELO
Capitalization1.05B45.4M2,302%
EBITDA-197.92M-16.08M1,231%
Gain YTD18.430-68.447-27%
P/E RatioN/AN/A-
Revenue32.9M0-
Total Cash553M754K73,342%
Total Debt142MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ABCLTELO
RSI
ODDS (%)
Bullish Trend 7 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 7 days ago
81%
Momentum
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
79%
MACD
ODDS (%)
Bullish Trend 7 days ago
80%
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
79%
Bearish Trend 7 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 15 days ago
85%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
TELO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CERT9.270.42
+4.80%
Certara
MRUS95.990.05
+0.05%
Merus NV
ATNM1.37N/A
N/A
Actinium Pharmaceuticals
JSAIY17.32N/A
N/A
J Sainsbury plc
LRMR3.12-0.43
-12.11%
Larimar Therapeutics

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
N/A
RXRX - ABCL
58%
Loosely correlated
-0.69%
CRSP - ABCL
57%
Loosely correlated
-1.13%
ABSI - ABCL
56%
Loosely correlated
+0.16%
VCYT - ABCL
56%
Loosely correlated
-0.43%
DNA - ABCL
52%
Loosely correlated
-0.69%
More

TELO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TELO has been loosely correlated with CRSP. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if TELO jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELO
1D Price
Change %
TELO100%
+0.78%
CRSP - TELO
34%
Loosely correlated
-1.13%
ABCL - TELO
31%
Poorly correlated
N/A
ENGN - TELO
29%
Poorly correlated
-0.32%
GLTO - TELO
29%
Poorly correlated
+7.37%
LITS - TELO
29%
Poorly correlated
+5.26%
More